Mean liver weight (g) (A), liver weight/body ratio (B), hepatic triglyceride (mg/g) (C) and hepatic steatosis quantification (% area) (D) upon completion of the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

Schematic overview of the experimental groups. by Elsie D. Oduor (22521785)

Subjects:

Line graph illustrating mean food intake (in grams) at weekly intervals during the induction phase. by Elsie D. Oduor (22521785)

Subjects:

Mean blood glucose responses (mmol/L) to an oral blood glucose bolus 2g/kg during a 120-minute period and mean area under the curve (mmol/L.min) during the oral blood glucose toler... by Elsie D. Oduor (22521785)

Subjects:

Mean mesenteric, retroperitoneal, pericardial, and total visceral adipose tissue weights (in grams) upon completion of the experiment. by Elsie D. Oduor (22521785)

Subjects:

Line graph illustrating mean body weight (in grams) at weekly intervals during the induction phase. by Elsie D. Oduor (22521785)

Subjects:

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

Line graph illustrating mean body weight (in grams) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

Mean lipid profile (mmol/L) upon completion of the experimental period. by Elsie D. Oduor (22521785)

Subjects:

Line graph illustrating mean food intake (g) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

Mean blood glucose responses (mmol/L) to an oral blood glucose bolus 2g/kg during a 120-minute period and mean area under the curve (mmol/L.min) during the oral blood glucose toler... by Elsie D. Oduor (22521785)

Subjects:

Representative liver histology of normal control (A), low-dose Olanzapine (B), negative control (C), test (D), and positive control (E) groups (Hematoxylin and Eosin stain, ×400 ma... by Elsie D. Oduor (22521785)

Subjects:

EF-24 induces significant transcriptional changes in K-562 cells. by Ajeet P. Singh (22298432)

Subjects:

Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

Subjects:

Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

Subjects:

Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

Subjects: